Latest Headlines
PR Newswire
ESMO 2024 - ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients
7 小时前
PR Newswire
Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC at ESMO 2024
10 小时前
PR Newswire
New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
11 小时前
PR Newswire
At Congressional Black Caucus Foundation's Phoenix Awards, President Biden And Vice President Harris Urge Caucus To Advance Their Vision For The Future Ahead Of The Presidential Election.
13 小时前
PR Newswire
Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together
18 小时前
It's better on the app
👈 Scan the QR code to download